These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Rao QA; Newhouse JH Radiology; 2006 May; 239(2):392-7. PubMed ID: 16543592 [TBL] [Abstract][Full Text] [Related]
3. Contrast-induced nephropathy after intravenous administration: fact or fiction? Katzberg RW; Lamba R Radiol Clin North Am; 2009 Sep; 47(5):789-800, v. PubMed ID: 19744594 [TBL] [Abstract][Full Text] [Related]
4. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage]. Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166 [No Abstract] [Full Text] [Related]
5. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage]. Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021 [No Abstract] [Full Text] [Related]
6. [Nephropathy induced by a contrast medium--comments on risk factors and prevention]. Aurell M; Boijsen M Lakartidningen; 1992 Jun; 89(24):2180. PubMed ID: 1630247 [No Abstract] [Full Text] [Related]
17. Prevention of contrast-induced nephropathy: a pharmacological overview. Anderson AL; Smith KM Orthopedics; 2006 Oct; 29(10):893-5. PubMed ID: 17061415 [TBL] [Abstract][Full Text] [Related]